WARNER, Digby F
and
MIZRAHI, Valerie. Approaches to target identification and validation for tuberculosis drug discovery: A University of Cape Town perspective. SAMJ, S. Afr. med. j. [online].
2012,
vol.102, n.6, pp. 457-461.
ISSN 0256-9574.
|
|
2. http://www.dst.gov.za/publications-policies/strategies-reports/The%20Ten-Year%20Plan%20for%20Science%20and%20Technology.pdf (accessed February 2012). [ Links ] 3. Dye C. Global epidemiology of tuberculosis. Lancet 2006;367(9514):938-940. [http://dx.doi.org/10.1016/S0140-6736(06)68384-0] [ Links ] 4. World Health Organization (WHO). Global Tuberculosis Control - Surveillance, Planning, Financing Geneva: WHO, 2010. [ Links ] 5. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011;469(7331):483-490. [http://dx.doi.org/10.1038/nature09657] [ Links ] 6. Barry CE 3rd, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009;7(12):845-855. [http://dx.doi.org/10.1038/nrmicro2236] [ Links ] 7. Russell DG, Barry CE 3rd, Flynn JL. Tuberculosis: what we don't know can, and does, hurt us. Science 2010;328(5980):852-826. [http://dx.doi.org/10.1126/science.1184784] [ Links ] 9. Djelouadji Z, Raoult D, Drancourt M. Palaeogenomics of Mycobacterium tuberculosis: epidemic bursts with a degrading genome. Lancet Infect Dis 2011;11(8):641-650. [http://dx.doi.org/10.1016/S1473-3099(11)70093-7] [ Links ] 10. Rhee KY, Carvalho LP, Bryk R, et al. Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol 2011;19(7):307-314. [http://dx.doi.org/10.1016/j.tim.2011.03.008] [ Links ] 11. Lew JM, Kapopoulou A, Jones LM, Cole ST. TubercuList - 10 years after. Tuberculosis (Edinb) 2011;91(1):1-7. [http://dx.doi.org/10.1016/j.tube.2010.09.008] [ Links ] 12. Sassetti CM, Boyd DH, Rubin EJ. Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci USA 2011;98(22):12712-12717. [http://dx.doi.org/10.1073/pnas.231275498] [ Links ] 13. Griffin JE, Gawronski JD, Dejesus MA, Ioerger TR, Akerley BJ, Sassetti CM. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog 2011;7(9):e1002251. [http://dx.doi.org/10.1371/journal.ppat.1002251] [ Links ] 14. De Carvalho LP, Fischer SM, Marrero J, Nathan C, Ehrt S, Rhee KY. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 2010;17(10):1122-1131. [http://dx.doi.org/10.1016/j.chembiol.2010.08.009] [ Links ] 15. Stumpf MP, Robertson BD, Duncan K, Young DB. Systems biology and its impact on anti-infective drug development. Prog Drug Res 2007;64(1):3-20. [http://dx.doi.org/10.1007/978-3-7643-7567-6_1] [ Links ] 16. Beste DJ, McFadden J. System-level strategies for studying the metabolism of Mycobacterium tuberculosis. Mol Biosyst 2010;6(12):2363-2372. [http://dx.doi.org/10.1039/c003757p] [ Links ] 17. Blumenthal A, Trujillo C, Ehrt S, Schnappinger D. Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo. PLoS One 2010;5(12):e15667. [http://dx.doi.org/10.1371/journal.pone.0015667] [ Links ] 18. Wei JR, Krishnamoorthy V, Murphy K, et al. Depletion of antibiotic targets has widely varying effects on growth. Proc Natl Acad Sci USA 2011;108(10):4176-4181. [http://dx.doi.org/10.1073/pnas.1018301108] [ Links ] 19. Falconer SB, Czarny TL, Brown ED. Antibiotics as probes of biological complexity. Nat Chem Biol 2011;17:415-423. [http://dx.doi.org/10.1038/nchembio.590] [ Links ] |
